Back to results
US 2016/0251653 A1Published application
Therapeutic compounds
AssigneeUniversity of Iowa Research Foundation
InventorsBeverly L. Davidson, Ryan L. Boudreau
Life of this patent
Estimating the term…
Abstract
The present invention is directed to RNA interference (RNAi) molecules targeted against a Huntington's disease nucleic acid sequence, and methods of using these RNAi molecules to treat Huntington's disease.
Claims26
1-72. (canceled)
A nucleic acid encoding an artificial primary miRNA transcript (pri-miRNA) comprising, in order of position, a 5′-flanking region, wherein the 5′-flanking region comprises a 5′-bulge sequence positioned upstream from a 5′-joining sequence;
- a non-guide region, wherein the 5′-joining sequence is contiguously linked to the non-guide region;
- a loop region;
- a guide region;
- and a 3′-flanking region, wherein the guide region comprises a sequence at least 80% identical to cgaccaugcgagccagca (miHDS.1 guide. SEQ ID NO:7) and the non-guide region is at least 80% complementary to the guide region.
1 more element
Dependencies are inferred from the claim text.